Core Viewpoint - The recent launch of the "National Medicine AI System" by Guoshengtang demonstrates the company's strategic advancement in integrating AI with traditional Chinese medicine, reinforcing its leadership in the smart healthcare sector [1] Company Developments - Guoshengtang's stock rose by approximately 4.46%, reaching HKD 33.7, with a trading volume of HKD 68.85 million [1] - The company showcased its "Traditional Chinese Medicine + AI" strategy at a conference in Guangzhou, highlighting significant achievements in the field [1] - Management anticipates that AI products will achieve large-scale commercialization by 2025, focusing on four key areas: providing scarce physician resources, training young physicians, enhancing user satisfaction, and accelerating the internationalization of traditional Chinese medicine [1] AI Integration and Services - By June 2025, Guoshengtang plans to launch its first "National Medicine AI Avatar," with a total of 10 AI avatars covering eight core specialties in traditional Chinese medicine by August [1] - The integration of AI technology aims to enhance the supply of quality traditional Chinese medical services, addressing the shortage of high-quality medical resources and providing standardized, efficient diagnostic experiences for patients [1] - The company has also introduced an AI health assistant to further improve the patient experience in diagnosis and treatment [1]
固生堂涨近5% “中医+AI”战略阶段性成果显著 公司料AI产品年内有望实现商业变现